By Bhanvi Satija LONDON, Feb 2 (Reuters) - French drugmaker Sanofi said on Monday that its experimental genetic disorder ...

Researchers led by the University of Vienna and Liège University Hospital Center have identified genetic variants associated ...

The EMA’s positive opinion on Kygevvi marks a turning point for patients with TK2d, an ultra-rare genetic muscle disease previously managed only with supportive care.

On Wednesday, Google's DeepMind AI research lab announced AlphaGenome, an AI model designed to identify disease markers in large volumes of genetic data. It's badly needed in a field that has produced ...

A new AI model from Google DeepMind called AlphaGenome can predict how DNA mutations affect biological processes, helping pinpoint genes linked to diseases and speeding up drug discovery.

Fixing gene defects with designer DNA is on the horizon after Google DeepMind launched a pioneering new AI tool.

Google DeepMind's AlphaGenome AI can analyse long stretches of DNA to predict how hidden genetic changes affect gene regulation and disease risk, offering new insights into cancer and other disorders.

It could transform our understanding of why diseases develop and the medicines needed to treat them, says researchers.

Ancient DNA from a 5,500-year-old skeleton in Colombia reveals the oldest genome of "Treponema pallidum" yet, sharpening ...

Patients in the EU with rare disease thymidine kinase 2 deficiency (TK2d) could be just weeks away from having the first ...

Google DeepMind has introduced AlphaGenome, an AI tool that analyses large sections of DNA to predict how genetic mutations ...